The Limited Times

Now you can see non-English news...

Jean-Pierre Robin: "Faced with Covid-19, the French are reluctant to calculate probabilities"

2021-04-12T17:41:26.636Z


ANALYSIS - Why are the benefit-cost analyzes of the AstraZeneca vaccine - which prove that the risk of thrombosis is statistically much lower than the possibility of succumbing to the coronavirus - fail to convince?


Public opinion has its reasons that medical reason ignores.

With an overwhelming majority of 71%, the French do not trust the AstraZeneca vaccine, according to an Odoxa-Backbone Consulting poll for

Le Figaro

and Franceinfo published last week.

The rejection is all the more impressive as 70% of our compatriots now wish to be vaccinated.

At least good news, because barely 42% were in favor of vaccination in December 2020 in the country of Pasteur!

Read also: AstraZeneca vaccine: these health professionals who defy the advice of health authorities

In Great Britain, where more than 18 million people have received an injection of AstraZeneca, the British Medicines Agency (MHRA) has recorded seven deaths out of thirty rare cases of blood clots, an infinitesimal proportion.

With us, public health professors strive in vain to demonstrate that the benefits outweigh the risks.

According to calculations by Philippe Amouyel, from the Lille University Hospital, a person over 65 has a 1 in 110 risk of dying from Covid-19,

This article is for subscribers only.

You have 78% left to discover.

Subscribe: 1 € the first month

Can be canceled at any time

I ENJOY IT

Already subscribed?

Log in

Source: lefigaro

All news articles on 2021-04-12

You may like

Trends 24h

Latest

© Communities 2019 - Privacy

The information on this site is from external sources that are not under our control.
The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.